CM
WGS icon

Caption Management’s GeneDx Holdings WGS Stock Holding History

Caption Management’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-29,121
Closed -$2.95M – 1872
2022
Q1 		$2.95M Buy
29,121
+1,515
+5% +$168K 0.04% 605
2021
Q4 		$4.07M Buy
+27,606
New +$6.17M 0.05% 530

Other funds holding WGS

CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
ZDA
Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Caption Management's WGS Position: Q2 2022 in Review

Caption Management sold out of GeneDx Holdings (WGS) in Q2 2022, closing a stake of 25,994 shares — an estimated $2.63M sold.

Caption Management first reported a position in WGS in Q4 2021 and held it in 2 quarters. The position peaked at $2.63M in Q1 2022. 111 funds tracked by Wall St. Rank hold WGS as of Q2 2022.

  • Caption Management reported no remaining GeneDx Holdings position as of Q2 2022 after selling out during the quarter.
  • Caption Management sold 25,994 GeneDx Holdings shares in Q2 2022, an estimated $2.63M.
  • Caption Management first reported a position in GeneDx Holdings in Q4 2021 and held it in 2 quarters.
  • Caption Management's GeneDx Holdings position peaked at $2.63M in Q1 2022.
  • 111 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2022.

Based on Caption Management's 13F filing for Q2 2022, filed 15 Aug 2022.